Huaren Pharmaceutical Co Ltd Net Asset Quality Index
Huaren Pharmaceutical Co Ltd net asset quality index. Huaren Pharmaceutical Co Ltd (300110) has a Net Asset Quality Index of 33.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.79 Billion minus total liabilities of CN¥1.86 Billion yields net assets of CN¥925.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Huaren Pharmaceutical Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Huaren Pharmaceutical Co Ltd (2007–2025)
Net asset quality index of Huaren Pharmaceutical Co Ltd from 2007 to 2025. This chart shows how Huaren Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 33.2%, representing net assets of CN¥925.86 Million against total assets of CN¥2.79 Billion CNY. Check how strategically is Huaren Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Huaren Pharmaceutical Co Ltd Net Asset Quality Index by Year (2007–2025)
Huaren Pharmaceutical Co Ltd net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Huaren Pharmaceutical Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300110 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 33.6% | CN¥909.06 Million | CN¥2.70 Billion | CN¥1.79 Billion | ▼ -6.4 pp |
| 2024 | 40.1% | CN¥1.37 Billion | CN¥3.43 Billion | CN¥2.05 Billion | ▼ -13.5 pp |
| 2023 | 53.5% | CN¥2.77 Billion | CN¥5.17 Billion | CN¥2.40 Billion | ▲ +3.2 pp |
| 2022 | 50.4% | CN¥2.60 Billion | CN¥5.16 Billion | CN¥2.56 Billion | ▲ +7.0 pp |
| 2021 | 43.3% | CN¥2.44 Billion | CN¥5.64 Billion | CN¥3.20 Billion | ▼ -24.9 pp |
| 2020 | 68.2% | CN¥2.33 Billion | CN¥3.42 Billion | CN¥1.09 Billion | ▼ -14.8 pp |
| 2019 | 83.0% | CN¥2.25 Billion | CN¥2.71 Billion | CN¥461.81 Million | ▲ +11.4 pp |
| 2018 | 71.5% | CN¥2.25 Billion | CN¥3.15 Billion | CN¥897.11 Million | ▲ +17.9 pp |
| 2017 | 53.6% | CN¥1.55 Billion | CN¥2.89 Billion | CN¥1.34 Billion | ▼ -2.4 pp |
| 2016 | 56.0% | CN¥1.53 Billion | CN¥2.72 Billion | CN¥1.20 Billion | ▲ +3.6 pp |
| 2015 | 52.4% | CN¥1.44 Billion | CN¥2.75 Billion | CN¥1.31 Billion | ▼ -4.1 pp |
| 2014 | 56.4% | CN¥1.48 Billion | CN¥2.62 Billion | CN¥1.14 Billion | ▼ -5.2 pp |
| 2013 | 61.7% | CN¥1.46 Billion | CN¥2.37 Billion | CN¥907.56 Million | ▼ -13.4 pp |
| 2012 | 75.0% | CN¥1.34 Billion | CN¥1.78 Billion | CN¥445.69 Million | ▼ -20.5 pp |
| 2011 | 95.5% | CN¥1.19 Billion | CN¥1.25 Billion | CN¥55.77 Million | ▼ -0.3 pp |
| 2010 | 95.9% | CN¥1.10 Billion | CN¥1.15 Billion | CN¥47.60 Million | ▲ +46.5 pp |
| 2009 | 49.4% | CN¥313.80 Million | CN¥635.78 Million | CN¥321.98 Million | ▲ +5.8 pp |
| 2008 | 43.6% | CN¥221.03 Million | CN¥507.33 Million | CN¥286.30 Million | ▼ -7.4 pp |
| 2007 | 51.0% | CN¥184.68 Million | CN¥362.18 Million | CN¥177.50 Million | — |